================================================================================
                         QUEST DIAGNOSTICS INCORPORATED
                         Laboratory Test Report
================================================================================

Patient Information:
  Name: CHEN, SARAH
  DOB: 1993-03-15 (Age: 32)
  Sex: Female
  Patient ID: SARAH_CHEN_001

Ordering Physician: Dr. Emily Martinez, MD
Facility: Mission Health Center, San Francisco, CA

Specimen Information:
  Collection Date: 2025-07-15 08:15 AM
  Received Date: 2025-07-15 10:30 AM
  Report Date: 2025-07-15 16:45 PM
  Specimen: Blood, Venous
  Fasting Status: 10 hours fasting
  Lab Order ID: LAB-2025-071501

================================================================================
                            TEST RESULTS
================================================================================

COMPREHENSIVE METABOLIC PANEL
--------------------------------------------------------------------------------
Test Name                    Result      Units    Reference Range        Flag
--------------------------------------------------------------------------------
Glucose, Fasting             105         mg/dL    65-99                  H
Sodium                       140         mmol/L   136-145
Potassium                    4.2         mmol/L   3.5-5.1
Chloride                     102         mmol/L   98-107
Carbon Dioxide               25          mmol/L   22-30
BUN                          14          mg/dL    7-20
Creatinine                   0.9         mg/dL    0.6-1.2
eGFR                         >90         mL/min   >60
Calcium                      9.5         mg/dL    8.6-10.2
Albumin                      4.3         g/dL     3.5-5.0
Total Protein                7.1         g/dL     6.0-8.3
AST (SGOT)                   28          U/L      10-40
ALT (SGPT)                   32          U/L      7-56
Alkaline Phosphatase         68          U/L      30-120
Total Bilirubin              0.6         mg/dL    0.2-1.2

DIABETES MONITORING
--------------------------------------------------------------------------------
Test Name                    Result      Units    Reference Range        Flag
--------------------------------------------------------------------------------
Hemoglobin A1c               5.9         %        <5.7 (Normal)          H
                                                  5.7-6.4 (Prediabetes)
                                                  ≥6.5 (Diabetes)

Interpretation: PREDIABETES
  Patient shows elevated HbA1c consistent with prediabetes. Recommend
  lifestyle modification and 3-month follow-up testing.

Insulin, Fasting             14.2        µU/mL    2.6-24.9
HOMA-IR (Calculated)         3.7         index    <2.0 (Sensitive)       H
                                                  2.0-3.0 (Early IR)
                                                  >3.0 (Resistant)

Interpretation: INSULIN RESISTANCE
  HOMA-IR = (Fasting Glucose × Fasting Insulin) / 405
  HOMA-IR = (105 × 14.2) / 405 = 3.7
  Result indicates significant insulin resistance.

LIPID PANEL
--------------------------------------------------------------------------------
Test Name                    Result      Units    Reference Range        Flag
--------------------------------------------------------------------------------
Total Cholesterol            194         mg/dL    <200 (Desirable)
Triglycerides                142         mg/dL    <150
HDL Cholesterol              52          mg/dL    >50 (Female)
LDL Cholesterol (Calc)       118         mg/dL    <100 (Optimal)         H
                                                  100-129 (Near Optimal)
VLDL Cholesterol (Calc)      28          mg/dL    <30
Total/HDL Ratio              3.7                  <5.0 (Optimal)

INFLAMMATORY MARKERS
--------------------------------------------------------------------------------
Test Name                    Result      Units    Reference Range        Flag
--------------------------------------------------------------------------------
C-Reactive Protein (hs)      0.7         mg/L     <1.0 (Low CV Risk)
                                                  1.0-3.0 (Average Risk)
                                                  >3.0 (High Risk)

Interleukin-6 (IL-6)         1.1         pg/mL    <1.8

TNF-alpha                    2.3         pg/mL    <2.8

OXIDATIVE STRESS MARKER
--------------------------------------------------------------------------------
Test Name                    Result      Units    Reference Range        Flag
--------------------------------------------------------------------------------
8-OHdG (Urine)               4.2         ng/mL    <5.0 (Normal)
                                                  5.0-8.0 (Elevated)
                                                  >8.0 (High)

METABOLIC MARKERS
--------------------------------------------------------------------------------
Test Name                    Result      Units    Reference Range        Flag
--------------------------------------------------------------------------------
Adiponectin                  8.2         µg/mL    >10 (Protective)       L

Interpretation: LOW ADIPONECTIN
  Low adiponectin levels associated with insulin resistance and
  increased cardiovascular risk. Recommend weight management and
  exercise intervention.

THYROID FUNCTION
--------------------------------------------------------------------------------
Test Name                    Result      Units    Reference Range        Flag
--------------------------------------------------------------------------------
TSH                          2.1         µIU/mL   0.4-4.5

================================================================================
                        CLINICAL INTERPRETATION
================================================================================

FINDINGS:
  1. PREDIABETES CONFIRMED
     - HbA1c: 5.9% (diagnostic threshold: 5.7-6.4%)
     - Fasting Glucose: 105 mg/dL (impaired fasting glucose: 100-125 mg/dL)
     - Patient meets ADA criteria for prediabetes diagnosis

  2. INSULIN RESISTANCE PRESENT
     - HOMA-IR: 3.7 (normal <2.0)
     - Fasting Insulin: 14.2 µU/mL (upper-normal range)
     - Low adiponectin: 8.2 µg/mL (protective >10)
     - Findings consistent with metabolic syndrome precursor state

  3. LIPID PROFILE: BORDERLINE
     - LDL cholesterol near optimal-borderline (118 mg/dL)
     - Triglycerides upper-normal (142 mg/dL)
     - HDL adequate for female (52 mg/dL)

  4. INFLAMMATORY MARKERS: NORMAL
     - CRP: 0.7 mg/L (low cardiovascular risk)
     - IL-6, TNF-alpha within normal limits
     - No evidence of chronic systemic inflammation at this time

  5. OXIDATIVE STRESS: NORMAL
     - 8-OHdG: 4.2 ng/mL (within normal range)
     - No significant oxidative DNA damage detected

RISK ASSESSMENT:
  - 5-Year Type 2 Diabetes Risk: 40% (without intervention)
  - 10-Year Cardiovascular Disease Risk: 2% (Framingham)
  - Metabolic Syndrome: Not meeting full criteria (3/5 components)

RECOMMENDATIONS:
  1. Lifestyle Modification Program
     - Structured weight loss (target: 5-10% body weight)
     - Resistance training 3x/week
     - Mediterranean-style diet
     - Target: 150 min/week moderate-intensity aerobic activity

  2. Follow-up Testing
     - Repeat HbA1c, glucose, insulin in 3 months
     - Annual comprehensive metabolic panel
     - Consider continuous glucose monitoring

  3. Genetic Counseling (if indicated)
     - Patient has family history of Type 2 Diabetes
     - May benefit from genetic risk assessment (TCF7L2, GSTM1 variants)

  4. Environmental Factors
     - Assess air quality exposure
     - Consider antioxidant support if high pollution exposure

PHYSICIAN NOTES:
  Patient is health-conscious software engineer, currently living in
  San Francisco (low air pollution). Despite normal inflammatory markers,
  metabolic dysfunction is already present (prediabetes, insulin resistance).

  Of particular concern: Patient is planning to relocate to Los Angeles
  within 2 months. Recommend monitoring biomarkers closely post-relocation
  due to significantly higher PM2.5 exposure in LA area.

  Patient's genetic background (Asian ethnicity + family history) increases
  diabetes risk. Early intervention critical to prevent progression.

================================================================================

Electronically signed by: Emily Martinez, MD
Date/Time: 2025-07-15 16:45 PM PST

Laboratory Director: Robert Chen, MD, PhD
CLIA #: 05D0950582
CAP #: 7172534

Quest Diagnostics Incorporated
1 Malcolm Ave, Teterboro, NJ 07608
Phone: 1-866-MY-QUEST (1-866-697-8378)
www.QuestDiagnostics.com

================================================================================
                              END OF REPORT
================================================================================

IMPORTANT NOTES:
- This report is confidential and intended solely for the ordering physician
  and the patient named above
- Reference ranges may vary by laboratory and testing methodology
- Clinical correlation with patient history and examination is recommended
- For questions regarding results, contact the ordering physician

Test results have been reviewed and released by the performing laboratory
pursuant to applicable state and federal regulations.

Report ID: QD-2025-071501-SF
Page 1 of 1
